共 50 条
- [1] Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myelomaBlood Cancer Journal, 10Alejandro MedinaNoemi PuigJuan Flores-MonteroCristina JimenezM.-Eugenia SarasqueteMaría Garcia-AlvarezIsabel Prieto-CondeCarmen ChillonMiguel AlcocebaNorma C. GutierrezAlbert OriolLaura RosinolJoan BladèMercedes GironellaMiguel T. HernandezVeronica Gonzalez-CalleMaria-Teresa CedenaBruno PaivaJesus F. San-MiguelJuan-Jose LahuertaMaria-Victoria MateosJoaquin Martinez-LopezAlberto OrfaoMarcos GonzalezRamon Garcia-Sanz
- [2] Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myelomaBLOOD CANCER JOURNAL, 2020, 10 (10)Medina, AlejandroPuig, NoemiFlores-Montero, JuanJimenez, CristinaSarasquete, M. -EugeniaGarcia-Alvarez, MariaPrieto-Conde, IsabelChillon, CarmenAlcoceba, MiguelGutierrez, Norma C.Oriol, AlbertRosinol, LauraBlade, JoanGironella, MercedesHernandez, Miguel T.Gonzalez-Calle, VeronicaCedena, Maria-TeresaPaiva, BrunoSan-Miguel, Jesus F.Lahuerta, Juan-JoseMateos, Maria-VictoriaMartinez-Lopez, JoaquinOrfao, AlbertoGonzalez, MarcosGarcia-Sanz, Ramon
- [3] Next Generation Flow (NGF) for High Sensitive Detection of Minimal Residual Disease (MRD) in Multiple Myeloma (MM)BLOOD, 2015, 126 (23)Flores-Montero, Juan A.Paiva, BrunoSanoja-Flores, LuzalbaPuig, NoemiGarcia, OmarBoettcher, SebastianPerez-Moran, Jose J.Belen Vidriales, MariaMateos, Maria-VictoriaGarcia-Sanz, RamonJimenez, CristinaGonzalez, MarcosMartinez-Lopez, JoaquinConsuelo Canizo, MariaSan Miguel, JesusDurie, Brianvan Dongen, Jacques J. M.Orfao, Alberto
- [4] Comparison of Next-Generation Flow Cytometry (NGF) and Next-Generation Sequencing (NGS) in the Assessment of Minimal Residual Disease in Multiple MyelomaBLOOD, 2022, 140 : 7249 - 7250Wang, QingqingYao, LiZhu, MingqingYan, LingzhiJin, SongShang, JingjingShi, XiaolanZhai, YingyingYan, ShuangYao, WeiqinYou HongyingWu, DepeiFu, Chengcheng
- [5] MINIMAL RESIDUAL DISEASE DETECTION BY NEXT GENERATION FLOW-MRD IN MULTIPLE MYELOMA PATIENTSHAEMATOLOGICA, 2016, 101 : S87 - S87Sirianni, S.Gozzetti, A.Candi, V.Bocchia, M.Raspadori, D.
- [6] Discordances between Immunofixation (IFx) and Minimal Residual Disease (MRD) Assessment with Next-Generation Flow (NGF) and Sequencing (NGS) in Patients (Pts) with Multiple Myeloma (MM): Clinical and Pathogenic SignificanceBLOOD, 2020, 136Rodriguez, SaraGoicoechea, IbaiGemenetzi, KaterinaBotta, CirinoAgathangelidis, AndreasPuig, NoemiCedena, Maria TeresaMedina, AlejandroValdes-Mas, RafaelGarces, Juan JosePerez, Jose J.Burgos, LeireCalasanz, Maria JoseAlignani, DiegoVilas-Zornoza, AmaiaSarai, SarvideProsper, FelipeMartinez-Climent, Jose AngelOrfao, AlbertoGarcia-Sanz, RamonUbieto, Ana JimenezLopez, Joaquin MartinezLahuerta, Juan JoseRosinol, LauraBlade, JoanMateos, Maria-VictoriaChatzidimitriou, AnastasiaSan-Miguel, Jesus F.Paiva, Bruno
- [7] Multiparameter flow cytometry (MFC) and next generation sequencing (NGS) for minimal residual disease (MRD) evaluation: Results of the FORTE trial in newly diagnosed multiple myeloma (MM).JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)Oliva, StefaniaGenuardi, ElisaBelotti, AngeloFrascione, Pio Manlio MirkoGalli, MonicaCapra, AndreaOffidani, MassimoVozella, FedericoZambello, RenatoAuclair, DanielKirsch, IlanRuggeri, MarinaJacob, AllisonLedda, AntonioCorradini, PaoloGilestro, MilenaZamagni, ElenaMusto, PellegrinoBoccadoro, MarioGay, Francesca
- [8] Precision Medicine Based on the Achievement of Sustained Undetectable Minimal Residual Disease (MRD) By Next-Generation Flow (NGF) and Imaging Leads to Significant Reduction in Risk of Progression of Patients with Multiple Myeloma (MM)BLOOD, 2019, 134De La Puerta Rueda, Jose EnriqueBurgos, LeireLetamendi Madariaga, GaraziMartinez Bilbao, CristinaAtutxa Aresti, LuisOjanguren Bergaz, JesusOlivares Salaverri, MatxalenSancho Garaizabal, BegonaUriarte, IsabelVicente Olabarria, InigoPerez Garay, Raquelde Juan Arroyo, AnaAmarika Ibarrondo, ItxasoCarrascosa Vallejo, TomasCasado Diez, AmaiaCortes Fernandez, CristinaEtxeguren Urkixo, IanireGainza Gonzalez, EukeneGonzalez Vallejo, InesGoikolea Ugarte, JavierBarredo Santamaria, InmaculadaSaiz Lopez, AlbertoVazquez Rodriguez, AntonioUrrechaga Igartua, EloisaEreno Ealo, Maria JoseMontejo Rodrigo, EstibalitzPastor Ausin, ElixabeteCabrera Zubizarreta, AlbertoOntanon Garces, Jose MariaSaralegui Prieto, IboneMaruri Machado, NataliaArana Berganza, PaulaCelis Alvarez, MaraAranbarri Larranaga, AneIbarrondo Chamorro, PalomaPaiva, Bruno
- [9] Impact of Minimal Residual Disease (MRD) By Multiparameter Flow Cytometry (MFC) and Next-Generation Sequencing (NGS) on Outcome: Results of Newly Diagnosed Transplant-Eligible Multiple Myeloma (MM) Patients Enrolled in the Forte TrialBLOOD, 2020, 136Oliva, StefaniaGenuardi, ElisaPetrucci, Maria TeresaD'Agostino, MattiaAuclair, DanielSpadano, AntonioJacob, Allison P.Cea, MicheleDe Rosa, LucaGozzetti, AlessandroRuggeri, MarinaCapra, AndreaGilestro, MilenaPescosta, NorbertPalmas, Angelo D.Siniscalchi, AgostinaKirsch, Ilan R.Corradini, PaoloMusto, PellegrinoBoccadoro, MarioZamagni, ElenaGay, Francesca
- [10] Next Generation Flow for Multiple Myeloma Minimal Residual Disease: Igh Rearrangement NGS Is Complement to the NGFBLOOD, 2018, 132Kim, Sung-MinKim, Jung-AhJeong, DajeongYun, JiwonLim, Kyu MinHwang, Sang MeeYoon, Sung-SooLee, Dong Soon